Skip to main content
Ocumension Therapeutics logo

Ocumension Therapeutics — Investor Relations & Filings

Ticker · 1477 ISIN · KYG674111011 LEI · 5493000USURI3SIL4Z85 HKEX Manufacturing
Open in API
Filings indexed 459 across all filing types
Latest filing 2025-04-02 Share Issue/Capital Cha…
Country KY Cayman Islands
Listing HKEX 1477

About Ocumension Therapeutics

http://www.ocumension.com

Ocumension Therapeutics is an ophthalmic pharmaceutical platform company dedicated to the research, development, and commercialization of first-in-class or best-in-class therapeutics. The company focuses on providing comprehensive treatment solutions for Chinese patients suffering from ocular diseases. Ocumension has established a complete ophthalmic drug product line, currently holding 20 drug assets covering both anterior and posterior segments of the eye. Its portfolio addresses major conditions such as chronic non-infectious uveitis, infective and allergic conjunctivitis, and diabetic macular edema. The company employs a strategy combining continuous scientific innovation, independent R&D, and strategic alliances to sustain the supply of innovative products across the ophthalmology field.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 March 2025
Share Issue/Capital Change Classification · 85% confidence The document is a standardized monthly "Return for Equity Issuer and Hong Kong Depositary Receipts under Chapter 19B" (Form FF301) filed with the HKEX. It details movements in authorized share capital, issued and treasury shares, share options, warrants, and other share arrangements across the month. This is not an annual or interim financial report, nor an earnings release or management discussion—rather, it specifically reports share capital changes. Therefore, it falls under "Share Issue/Capital Change" (SHA).
2025-04-02 English
PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION AND ADOPTION OF THE SEVENTH MEMORANDUM AND ARTICLES OF ASSOCIATION
Governance Information Classification · 85% confidence The document is an announcement under Rule 13.51(1) of the HK Listing Rules regarding proposed amendments to the Company’s memorandum and articles of association (its constitutional governance documents), to be approved at the forthcoming AGM. It does not present full financial results, share issuance details, or voting results, nor is it merely a notice of report publication. It specifically concerns governance changes to the Company’s internal rules. This falls squarely under Governance Information (CGR).
2025-03-31 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024
Earnings Release Classification · 90% confidence The document is the “Annual Results Announcement for the Year Ended December 31, 2024” published by a Hong Kong–listed company (stock code 1477). It contains audited consolidated annual results, business highlights, financial highlights, corporate profile, and detailed Management Discussion & Analysis. This is the initial public release of the full‐year financial results, consistent with what we classify as an Earnings Release (ER). It is not the full formal annual report (10‐K) but is a comprehensive earnings announcement. FY 2024
2025-03-31 English
DATE OF BOARD MEETING
Regulatory Filings Classification · 78% confidence The document is a short regulatory announcement notifying shareholders of the date of the board meeting to consider and approve the annual results (and potential final dividend). It does not contain the actual financial results or attach any report, nor does it change board composition or executive management. It is therefore a miscellaneous regulatory filing that does not fit any other specific category.
2025-03-17 English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 28 February 2025
Share Issue/Capital Change Classification · 85% confidence The document is a statutory monthly return (Form FF301) filed to HKEX detailing movements in the company’s authorized and issued share capital, treasury shares, share option exercises, warrant issues, share award schemes, and repurchases during the month. It is not an AGM presentation, earnings release, or long‐form report but a regulatory announcement of share capital changes. Therefore it best fits “Share Issue/Capital Change” (SHA).
2025-03-05 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 90% confidence The document is a statutory “Next Day Disclosure Return” under the Hong Kong Stock Exchange Listing Rules (FF305), detailing changes in issued shares and treasury shares, specifically the repurchase of shares (treasury shares) and related confirmations. It is not an earnings release or annual report but a transaction report of the company buying back its own shares. This falls squarely under “Transaction in Own Shares (Code: POS).”
2025-02-28 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.